ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,297.93
-0.01%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Gossamer Bio Inc (GOSS)

  7. Gossamer Bio Inc (GOSS) Noticias

GOSS Gossamer Bio Inc

0.5501
-0.0499 (-8.32%)
07 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Gossamer Bio Inc GOSS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0499 -8.32% 0.5501 23:00:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.60 0.5411 0.6267 0.5484 0.60
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/6/202415:30BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
06/6/202420:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202415:01BWGossamer Bio to Provide Updated Seralutinib TORREY..
10/5/202415:30BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
07/5/202415:02EDGAR2Form 8-K - Current report
07/5/202415:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202415:01BWGossamer Bio Announces First Quarter 2024 Financial Results..
06/5/202406:31EDGAR2Form 8-K - Current report
06/5/202406:30BWGossamer Bio and Chiesi Group Announce Transformative Global..
03/5/202407:02BWGossamer Bio Announces Publication of TORREY Phase 2 Results..
12/3/202406:31BWGossamer Bio Announces Appointment of Steven D. Nathan,..
05/3/202406:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202406:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202406:31EDGAR2Form 8-K - Current report
05/3/202406:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2023..
04/3/202415:02EDGAR2Form 8-K - Current report
08/1/202415:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
04/1/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:01BWGossamer Bio to Host Webcast to Discuss Latest Seralutinib..
05/12/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202316:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/12/202315:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
05/12/202306:01BWGossamer Bio Appoints Bob Smith as Chief Commercial Officer
29/11/202315:01EDGAR2Form 8-K - Current report
29/11/202306:01BWGossamer Bio Announces Appointment of John Quisel, J.D.,..
27/11/202315:01EDGAR2Form 8-K - Current report
22/11/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:31EDGAR2Form 8-K - Current report
09/11/202306:31BWGossamer Bio Announces Third Quarter 2023 Financial Results..
20/10/202315:01EDGAR2Form 8-K - Current report
03/10/202315:08BWGossamer Bio Announces Addition of Rainer Zimmermann, MD, as..
07/9/202316:00EDGAR2Form 8-K - Current report
07/9/202306:44BWGossamer Bio to Present Results of TORREY FRI Sub-Study at..
28/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
28/8/202315:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/8/202315:01EDGAR2Form DEL AM - Delaying amendment
18/8/202307:41EDGAR2Form S-3 - Registration statement under Securities Act of..
18/8/202307:38EDGAR2Form RW - Registration Withdrawal Request
17/8/202315:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
08/8/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:01EDGAR2Form 8-K - Current report
08/8/202315:01BWGossamer Bio Announces Second Quarter 2023 Financial Results..
28/7/202314:46EDGAR2Form SC 13D - General statement of acquisition of beneficial..

Su Consulta Reciente

NASDAQ
GOSS
Gossamer Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados